Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kieran F Docherty

Showing results (41-50 of 174) with videos related to

Pageof 18
Sort By:
Journal of the American College of Cardiology|September 1, 2024
Why Has it Been Challenging to Modify Kidney Disease Progression in Patients With Heart Failure?Muthiah Vaduganathan, Brendon L Neuen, Finnian McCausland, et al.
The Lancet. Digital Health|August 30, 2024
Digital tools in heart failure: addressing unmet needsPeder L Myhre, Jasper Tromp, Wouter Ouwerkerk, et al.
ESC Heart Failure|July 8, 2022
Within trial comparison of survival time projections from short-term follow-up with long-term follow-up findingsJoão Pedro Ferreira, Brian L Claggett, Kieran F Docherty, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|December 22, 2022
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?Kieran F Docherty, Antoni Bayes-Genis, Javed Butler, et al.
European Journal of Heart Failure|August 5, 2020
Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HFPhil McEwan, Oliver Darlington, John J V McMurray, et al.
JACC. Heart Failure|May 10, 2024
Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction: Insights From REVIVED-BCIS2Matthew Ryan, Dylan Taylor, Matthew Dodd, et al.
European Journal of Heart Failure|July 4, 2023
Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991-2016Kieran F Docherty, Alice M Jackson, Mark Macartney, et al.
European Journal of Heart Failure|June 27, 2023
Heart failure diagnosis in the general community - Who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Kieran F Docherty, Carolyn S P Lam, Amina Rakisheva, et al.
The Lancet. Diabetes & Endocrinology|August 19, 2019
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trialsSøren L Kristensen, Rasmus Rørth, Pardeep S Jhund, et al.
ESC Heart Failure|March 29, 2024
Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fractionKieran F Docherty, John J V McMurray, Paul R Kalra, et al.
Pageof 18

Showing results (41-50 of 174) with videos related to

Sort By:
Pageof 18
Journal of the American College of Cardiology|September 1, 2024
Why Has it Been Challenging to Modify Kidney Disease Progression in Patients With Heart Failure?Muthiah Vaduganathan, Brendon L Neuen, Finnian McCausland, et al.
The Lancet. Digital Health|August 30, 2024
Digital tools in heart failure: addressing unmet needsPeder L Myhre, Jasper Tromp, Wouter Ouwerkerk, et al.
ESC Heart Failure|July 8, 2022
Within trial comparison of survival time projections from short-term follow-up with long-term follow-up findingsJoão Pedro Ferreira, Brian L Claggett, Kieran F Docherty, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|December 22, 2022
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?Kieran F Docherty, Antoni Bayes-Genis, Javed Butler, et al.
European Journal of Heart Failure|August 5, 2020
Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HFPhil McEwan, Oliver Darlington, John J V McMurray, et al.
JACC. Heart Failure|May 10, 2024
Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction: Insights From REVIVED-BCIS2Matthew Ryan, Dylan Taylor, Matthew Dodd, et al.
European Journal of Heart Failure|July 4, 2023
Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991-2016Kieran F Docherty, Alice M Jackson, Mark Macartney, et al.
European Journal of Heart Failure|June 27, 2023
Heart failure diagnosis in the general community - Who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Kieran F Docherty, Carolyn S P Lam, Amina Rakisheva, et al.
The Lancet. Diabetes & Endocrinology|August 19, 2019
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trialsSøren L Kristensen, Rasmus Rørth, Pardeep S Jhund, et al.
ESC Heart Failure|March 29, 2024
Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fractionKieran F Docherty, John J V McMurray, Paul R Kalra, et al.
Pageof 18